Insights

Loading spinner
Gathering insights about Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc. Tech Stack

Y-mAbs Therapeutics, Inc. uses 8 technology products and services including Cloudflare CDN, cdnjs, Cloudflare, and more. Explore Y-mAbs Therapeutics, Inc.'s tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • cdnjs
    Content Delivery Network
  • Cloudflare
    Content Management System
  • Shopify
    E-commerce
  • React
    Javascript Frameworks
  • Webpack
    Miscellaneous
  • X-Content-Type-Options
    Miscellaneous
  • HSTS
    Security

Media & News

Y-mAbs Therapeutics, Inc.'s Email Address Formats

Y-mAbs Therapeutics, Inc. uses at least 1 format(s):
Y-mAbs Therapeutics, Inc. Email FormatsExamplePercentage
FL@ymabs.comJD@ymabs.com
37%
FLast@ymabs.comJDoe@ymabs.com
30%
FirstLast@ymabs.comJohnDoe@ymabs.com
20%
Last@ymabs.comDoe@ymabs.com
13%

Frequently Asked Questions

Where is Y-mAbs Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc.'s main headquarters is located at 230 Park Avenue 3350 New York, NY 10169 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Y-mAbs Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Y-mAbs Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Y-mAbs Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc. is a publicly traded company; the company's stock symbol is YMAB.

What is Y-mAbs Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc.'s official website is ymabs.com and has social profiles on LinkedIn.

How much revenue does Y-mAbs Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of September 2024, Y-mAbs Therapeutics, Inc.'s annual revenue reached $35M.

What is Y-mAbs Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Y-mAbs Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2024, Y-mAbs Therapeutics, Inc. has approximately 119 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: V. R.Chief Development Officer, Y-Mabs Therapeutics, Inc: N. L.Chief Financial Officer: P. P.. Explore Y-mAbs Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Y-mAbs Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Y-mAbs Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc.'s tech stack includes Cloudflare CDNcdnjsCloudflareShopifyReactWebpackX-Content-Type-OptionsHSTS.

What is Y-mAbs Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc.'s email format typically follows the pattern of . Find more Y-mAbs Therapeutics, Inc. email formats with LeadIQ.

How much funding has Y-mAbs Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2024, Y-mAbs Therapeutics, Inc. has raised $115M in funding. The last funding round occurred on Feb 17, 2021 for $115M.

When was Y-mAbs Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Y-mAbs Therapeutics, Inc. was founded in 2015.
Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc.

Biotechnology ResearchNew York, United States51-200 Employees

Y-mAbs is a commercial-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. We have a broad and advanced product pipeline, including pivotal-stage product candidates against a range of targets.

Our mission is to become the world leader in developing better and safer antibody-based oncology products addressing clear unmet pediatric and adult medical needs. With the right partnerships and collaborations, we envision changing the course of cancer care and its outcomes.

Section iconCompany Overview

Headquarters
230 Park Avenue 3350 New York, NY 10169 US
Phone number
Website
ymabs.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
YMAB
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $115M

    Y-mAbs Therapeutics, Inc. has raised a total of $115M of funding over 4 rounds. Their latest funding round was raised on Feb 17, 2021 in the amount of $115M.

  • $10M$50M

    Y-mAbs Therapeutics, Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $115M

    Y-mAbs Therapeutics, Inc. has raised a total of $115M of funding over 4 rounds. Their latest funding round was raised on Feb 17, 2021 in the amount of $115M.

  • $10M$50M

    Y-mAbs Therapeutics, Inc.'s revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.